Evolving management of metaplasia and dysplasia in Barrett's epithelium

Oesophageal cancer affects more than 450000 people worldwide and despite continued medical advancements the incidence of oesophageal cancer is increasing. Oesophageal cancer has a 5 year survival of 15%-25% and now globally attempts are made to more aggressively diagnose and treat Barrett’s oesophagus the known precursor to invasive disease. Currently diagnosis the of Barrett’s oesophagus is predominantly made after endoscopic visualisation and histopathological confirmation. Minimally invasive techniques are being developed to improve the viability of screening programs. The management of Barrett’s oesophagus can vary greatly dependent on the presence and severity of dysplasia. There is no consensus between the major international medical societies to determine and agreed surveillance and intervention pathway. In this review we analysed the current literature to demonstrate the evolving management of metaplasia and dysplasia in Barrett’s epithelium.

[1]  Nan Li,et al.  Efficacy and durability of radiofrequency ablation for Barrett's Esophagus: systematic review and meta-analysis. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  R. Sampliner,et al.  Progression or regression of barrett's esophagus—is it all in the eye of the beholder? , 2003, American Journal of Gastroenterology.

[3]  J. Hunter,et al.  Barrett’s Esophagus: A Review of the Literature , 2011, Journal of Gastrointestinal Surgery.

[4]  M. Sivak,et al.  Methylene blue staining of dysplastic and nondysplastic Barrett's esophagus: an in vivo and ex vivo study. , 2001, Endoscopy.

[5]  N. Shaheen,et al.  Safety and efficacy of endoscopic spray cryotherapy for Barrett's dysplasia: results of the National Cryospray Registry. , 2016, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[6]  M. Guelrud,et al.  Enhanced magnification endoscopy: a new technique to identify specialized intestinal metaplasia in Barrett's esophagus. , 2000, Gastrointestinal endoscopy.

[7]  A. Neugut,et al.  Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  A. Krasinskas,et al.  Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy. , 2009, The Annals of thoracic surgery.

[9]  Hugh Barr,et al.  Radiofrequency ablation and endoscopic mucosal resection for dysplastic barrett's esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry. , 2013, Gastroenterology.

[10]  M. Coleman,et al.  Continuing Rapid Increase in Esophageal Adenocarcinoma in England and Wales , 2008, The American Journal of Gastroenterology.

[11]  Jaw-Town Lin,et al.  The Application of Prague C and M Criteria in the Diagnosis of Barrett's Esophagus in an Ethnic Chinese Population , 2009, The American Journal of Gastroenterology.

[12]  H. El‐Serag,et al.  Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis , 2013, Gut.

[13]  E. Ito,et al.  Lower esophageal palisade vessels and the definition of Barrett's esophagus. , 2008, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[14]  E. Schoon,et al.  Remission of Barrett's esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study. , 2013, Gastroenterology.

[15]  R. Fitzgerald,et al.  Randomized crossover study comparing efficacy of transnasal endoscopy with that of standard endoscopy to detect Barrett's esophagus. , 2012, Gastrointestinal endoscopy.

[16]  Rebecca C Fitzgerald,et al.  British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus , 2013, Gut.

[17]  M. Guelrud,et al.  Acetic acid improves identification of remnant islands of Barrett's epithelium after endoscopic therapy. , 1998, Gastrointestinal endoscopy.

[18]  R. Sampliner,et al.  Diagnostic inconsistencies in Barrett's esophagus. Department of Veterans Affairs Gastroesophageal Reflux Study Group. , 1994, Gastroenterology.

[19]  A. Bhattacharyya,et al.  Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett’s oesophagus , 2003, Gut.

[20]  S. Spechler.  Barrett's oesophagus: diagnosis and management. , 2000, Bailliere's best practice & research. Clinical gastroenterology.

[21]  Patricia L. Blount,et al.  Safety of a systematic endoscopic biopsy protocol in patients with Barrett's esophagus , 2000, American Journal of Gastroenterology.

[22]  Peter D Siersema,et al.  Esophageal cancer. , 2008, Gastroenterology clinics of North America.

[23]  P. Fockens,et al.  Surveillance history of endoscopically treated patients with early Barrett's neoplasia: nonadherence to the Seattle biopsy protocol leads to sampling error. , 2008, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[24]  Sarmed S. Sami,et al.  Evaluation of a Minimally Invasive Cell Sampling Device Coupled with Assessment of Trefoil Factor 3 Expression for Diagnosing Barrett's Esophagus: A Multi-Center Case–Control Study , 2015, PLoS medicine.

[25]  J. Yeon,et al.  Application of the Prague C and M criteria for endoscopic description of columnar-lined esophagus in South Korea. , 2016, World journal of gastrointestinal endoscopy.

[26]  C. Pellegrini,et al.  The impact of laparoscopic anti-reflux surgery in patients with Barrett’s esophagus , 2014, Surgical Endoscopy.

[27]  A. Rastogi,et al.  Esophageal Adenocarcinoma in Barrett's Esophagus After Endoscopic Ablative Therapy: A Meta-Analysis and Systematic Review , 2009, The American Journal of Gastroenterology.

[28]  H. Welch,et al.  The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. , 2005, Journal of the National Cancer Institute.

[29]  P. Gatenby,et al.  Effect of antireflux surgery for Barrett's esophagus: long-term results. , 2016, Minerva chirurgica.

[30]  L. Murray,et al.  Sex-specific associations between body mass index, waist circumference and the risk of Barrett's oesophagus: a pooled analysis from the international BEACON consortium , 2013, Gut.

[31]  A. D. Pereira,et al.  Cancer risk in Barrett's oesophagus , 2007, European journal of gastroenterology & hepatology.

[32]  Prateek Sharma,et al.  Validation of the Prague C & M criteria for the endoscopic grading of Barrett's esophagus by gastroenterology trainees: a multicenter study. , 2010, Gastrointestinal endoscopy.

[33]  E. Kuipers,et al.  Proton pump inhibitors reduce the risk of neoplastic progression in patients with Barrett's esophagus. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[34]  S. Sami,et al.  High definition versus standard definition white light endoscopy for detecting dysplasia in patients with Barrett's esophagus. , 2015, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[35]  E. Kuipers,et al.  Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[36]  Kenneth K Wang,et al.  Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus , 1998, The American Journal of Gastroenterology.

[37]  B. Greenwald,et al.  Liquid nitrogen spray cryotherapy in Barrett's esophagus with high-grade dysplasia: long-term results. , 2012, Gastrointestinal endoscopy.

[38]  S. Franceschi,et al.  EPIDEMIOLOGY OF ESOPHAGEAL CANCER , 2013 .

[39]  R. Sampliner,et al.  Diagnostic inconsistencies in Barrett's esophagus , 1994 .

[40]  P. Fockens,et al.  High-resolution endoscopy plus chromoendoscopy or narrow-band imaging in Barrett's esophagus: a prospective randomized crossover study. , 2005, Endoscopy.

[41]  A. Sonnenberg,et al.  Risk Factors in the Development of Esophageal Adenocarcinoma , 2013, The American Journal of Gastroenterology.

[42]  Ravi N Sharaf,et al.  The role of endoscopy in Barrett's esophagus and other premalignant conditions of the esophagus. , 2012, Gastrointestinal endoscopy.

[43]  J. DesiletsDavid,et al.  Barrett's Esophagus in Practice: Gender and Screening Issues , 2014 .

[44]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[45]  Paul Fockens,et al.  Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett's oesophagus: a prospective, international, randomised controlled trial , 2012, Gut.

[46]  H. El‐Serag,et al.  Prevalence of Barrett's Esophagus in Asian Countries: A Systematic Review and Meta-analysis. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[47]  R. Fitzgerald,et al.  Rigorous Surveillance Protocol Increases Detection of Curable Cancers Associated with Barrett's Esophagus , 2001, Digestive Diseases and Sciences.

[48]  G. Lloyd,et al.  PTH-174 Non-endoscopic screening for barrett’s oesophagus: identifying neoplasia with infrared spectroscopy , 2015 .

[49]  D. Sautereau,et al.  French Society of Digestive Endoscopy SFED guideline: monitoring of patients with Barrett’s esophagus , 2007, Endoscopy.

[50]  M F Dixon,et al.  The Vienna classification of gastrointestinal epithelial neoplasia , 2000, Gut.

[51]  W H Henricks,et al.  Observer variation in the diagnosis of superficial oesophageal adenocarcinoma , 2002, Gut.

[52]  Laurence B. Lovat,et al.  Gastro-Esophageal Reflux Disease Symptoms and Demographic Factors as a Pre-Screening Tool for Barrett’s Esophagus , 2014, PloS one.

[53]  Fernando Ramos,et al.  A Randomized Comparison of Methylene Blue-Directed Biopsy Versus Conventional Four-Quadrant Biopsy for the Detection of Intestinal Metaplasia and Dysplasia in Patients With Long-Segment Barrett's Esophagus , 2008, The American Journal of Gastroenterology.

[54]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[55]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[56]  N. Shaheen,et al.  Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett's esophagus with advanced neoplasia. , 2012, Gastrointestinal endoscopy.

[57]  Jashanpreet Singh,et al.  The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis , 2011, Gut.

[58]  G. Darling,et al.  Validation of a new approach for mortality risk assessment in oesophagectomy for cancer based on age- and gender-corrected body mass index. , 2015, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[59]  J. Tijssen,et al.  Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. , 2014, JAMA.

[60]  R. Sandler,et al.  Is there publication bias in the reporting of cancer risk in Barrett's esophagus? , 2000, Gastroenterology.

[61]  Jan G P Tijssen,et al.  Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel , 2014, Gut.

[62]  M. Edelweiss,et al.  Does methylene blue detect intestinal metaplasia in Barrett's esophagus? , 2003, Gastrointestinal endoscopy.

[63]  R. Sampliner,et al.  Short segment Barrett's esophagus—the need for standardization of the definition and of endoscopic criteria , 1998, American Journal of Gastroenterology.

[64]  Christopher C Winchester,et al.  Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review , 2013, Gut.

[65]  J. Hunter,et al.  The Effect of Antireflux Surgery on Esophageal Carcinogenesis in Patients With Barrett Esophagus: A Systematic Review , 2007, Annals of surgery.

[66]  S. Spechler,et al.  Barrett esophagus and risk of esophageal cancer: a clinical review. , 2013, JAMA.

[67]  Ananya Das,et al.  Diagnostic yield of methylene blue chromoendoscopy for detecting specialized intestinal metaplasia and dysplasia in Barrett's esophagus: a meta-analysis. , 2009, Gastrointestinal endoscopy.

[68]  Prateek Sharma,et al.  American Gastroenterological Association medical position statement on the management of Barrett's esophagus. , 2011, Gastroenterology.

[69]  Michael Vieth,et al.  The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. , 2006, Gastroenterology.

[70]  K. Abrams,et al.  Meta analysis: cancer risk in Barrett’s oesophagus , 2007, Alimentary pharmacology & therapeutics.

[71]  R. Odze,et al.  Definition of Barrett's Esophagus: Time for a Rethink—Is Intestinal Metaplasia Dead? , 2009, The American Journal of Gastroenterology.

[72]  N. Soehendra,et al.  Long-term recurrence of neoplasia and Barrett's epithelium after complete endoscopic resection , 2014, Gut.

[73]  A. Sonnenberg,et al.  Length of Barrett's oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma , 2015, Gut.

[74]  R. Cestari,et al.  Endoscopic Mucosal Resection for High-Grade Dysplasia and Intramucosal Carcinoma Occurring in Barrett's Esophagus , 2004 .

[75]  W. Townsend,et al.  Unsedated transnasal endoscopy accurately detects Barrett's metaplasia and dysplasia. , 2002, Gastrointestinal endoscopy.

[76]  L. Murray,et al.  The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis. , 2008, American journal of epidemiology.